Occupe actuellement un poste chez Fate Therapeutics Inc
Position | Company | Period |
---|---|---|
General Counsel and Corporate Secretary | Fate Therapeutics Inc | 1 octobre 2015 - |
General Counsel | Fate Therapeutics Inc | 1 janvier 2009 - 1 octobre 2015 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-01-10 | 2024-01-09 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
10 874
-7.1%
4,3747 519 USD |
10 874 -7.1% | 4,37 | 47 519 USD | |
2023-01-11 | 2023-01-10 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
11 553
-6.1%
5,2460 538 USD |
11 553 -6.1% | 5,24 | 60 538 USD | |
2022-06-02 | 2022-06-01 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
25 000
-11.7%
22,96574 000 USD |
25 000 -11.7% | 22,96 | 574 000 USD | |
2022-04-04 | 2022-04-01 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
25 000
-11.7%
38,85971 250 USD |
25 000 -11.7% | 38,85 | 971 250 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
536
-0.3%
49,1526 344 USD |
536 -0.3% | 49,15 | 26 344 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
4 883
-3.0%
48,46236 630 USD |
4 883 -3.0% | 48,46 | 236 630 USD | |
2022-01-12 | 2022-01-10 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
643
-0.4%
47,1530 317 USD |
643 -0.4% | 47,15 | 30 317 USD | |
2022-01-12 | 2022-01-10 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
7 095
-4.2%
46,37328 995 USD |
7 095 -4.2% | 46,37 | 328 995 USD | |
2021-10-04 | 2021-10-01 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
11 844
-9.9%
59,68706 862 USD |
11 844 -9.9% | 59,68 | 706 862 USD | |
2021-10-04 | 2021-10-01 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
21 844
-15.4%
58,961 287 966 USD |
21 844 -15.4% | 58,96 | 1 287 966 USD | |
2021-10-04 | 2021-10-01 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
16 312
-10.3%
58,03946 634 USD |
16 312 -10.3% | 58,03 | 946 634 USD | |
2021-01-21 | 2021-01-19 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
200
-0.2%
117,0723 413 USD |
200 -0.2% | 117,07 | 23 413 USD | |
2021-01-21 | 2021-01-19 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
4 021
-4.3%
115,97466 333 USD |
4 021 -4.3% | 115,97 | 466 333 USD | |
2021-01-21 | 2021-01-19 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
14 944
-13.7%
115,091 719 935 USD |
14 944 -13.7% | 115,09 | 1 719 935 USD | |
2021-01-21 | 2021-01-19 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
15 835
-12.7%
114,111 806 959 USD |
15 835 -12.7% | 114,11 | 1 806 959 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
872
-1.0%
109,6595 618 USD |
872 -1.0% | 109,65 | 95 618 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
1 050
-1.1%
110,76116 296 USD |
1 050 -1.1% | 110,76 | 116 296 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
1 332
-1.4%
111,62148 673 USD |
1 332 -1.4% | 111,62 | 148 673 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
151
-0.2%
114,7617 328 USD |
151 -0.2% | 114,76 | 17 328 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
872
-0.9%
115,80100 977 USD |
872 -0.9% | 115,80 | 100 977 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
2 451
-2.5%
117,15287 144 USD |
2 451 -2.5% | 117,15 | 287 144 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
2 755
-2.8%
117,60323 985 USD |
2 755 -2.8% | 117,60 | 323 985 USD | |
2020-11-06 | 2020-11-05 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
2 600
-2.5%
51,15132 999 USD |
2 600 -2.5% | 51,15 | 132 999 USD | |
2020-11-06 | 2020-11-05 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
16 682
-14.0%
50,55843 253 USD |
16 682 -14.0% | 50,55 | 843 253 USD | |
2020-11-06 | 2020-11-04 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
51 519
-34.1%
50,412 597 140 USD |
51 519 -34.1% | 50,41 | 2 597 140 USD | |
2020-10-20 | 2020-10-16 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
29 199
-22.7%
50,251 467 212 USD |
29 199 -22.7% | 50,25 | 1 467 212 USD | |
2020-10-02 | 2020-10-01 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
6 983
-6.6%
41,95292 929 USD |
6 983 -6.6% | 41,95 | 292 929 USD | |
2020-10-02 | 2020-10-01 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
6 260
-5.6%
41,09257 234 USD |
6 260 -5.6% | 41,09 | 257 234 USD | |
2020-10-02 | 2020-10-01 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
21 757
-16.2%
40,26875 902 USD |
21 757 -16.2% | 40,26 | 875 902 USD | |
2020-01-10 | 2020-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
5 700
-5.4%
20,72118 085 USD |
5 700 -5.4% | 20,72 | 118 085 USD | |
2019-10-16 | 2019-10-15 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
10 200
-11.3%
14,24145 292 USD |
10 200 -11.3% | 14,24 | 145 292 USD | |
2017-10-17 | 2017-10-16 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
500
-1.1%
4,102 050 USD |
500 -1.1% | 4,10 | 2 050 USD | |
2017-10-17 | 2017-10-13 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
7 591
-14.2%
3,8329 074 USD |
7 591 -14.2% | 3,83 | 29 074 USD |